Logo image of CRAN-P.CA

CRANSTOWN CAPITAL CORP (CRAN-P.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:CRAN-P - CA22459L1031 - Common Stock

0.08 CAD
0 (0%)
Last: 5/8/2025, 7:00:00 PM
Fundamental Rating

2

Overall CRAN-P gets a fundamental rating of 2 out of 10. We evaluated CRAN-P against 0 industry peers in the Unkown industry. CRAN-P has a great financial health rating, but its profitability evaluates not so good. CRAN-P does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CRAN-P had negative earnings in the past year.
CRAN-P.CA Yearly Net Income VS EBIT VS OCF VS FCFCRAN-P.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -50K -100K -150K

1.2 Ratios

Industry RankSector Rank
ROA -13.64%
ROE -13.88%
ROIC N/A
ROA(3y)-17.37%
ROA(5y)N/A
ROE(3y)-17.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRAN-P.CA Yearly ROA, ROE, ROICCRAN-P.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30

1.3 Margins

CRAN-P does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRAN-P.CA Yearly Profit, Operating, Gross MarginsCRAN-P.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for CRAN-P remains at a similar level compared to 1 year ago.
There is no outstanding debt for CRAN-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRAN-P.CA Yearly Shares OutstandingCRAN-P.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M
CRAN-P.CA Yearly Total Debt VS Total AssetsCRAN-P.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 100K 200K 300K 400K

2.2 Solvency

CRAN-P has an Altman-Z score of 158.56. This indicates that CRAN-P is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for CRAN-P. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 158.56
ROIC/WACCN/A
WACCN/A
CRAN-P.CA Yearly LT Debt VS Equity VS FCFCRAN-P.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100K 200K 300K 400K

2.3 Liquidity

CRAN-P has a Current Ratio of 57.52. This indicates that CRAN-P is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 57.52 indicates that CRAN-P has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 57.52
Quick Ratio 57.52
CRAN-P.CA Yearly Current Assets VS Current LiabilitesCRAN-P.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100K 200K 300K 400K

More info and screens

0

3. Growth

3.1 Past

CRAN-P shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.38%.
EPS 1Y (TTM)-2.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CRAN-P reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRAN-P.CA Price Earnings VS Forward Price EarningsCRAN-P.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRAN-P.CA Per share dataCRAN-P.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0 0.01 0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRAN-P!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRANSTOWN CAPITAL CORP

TSX-V:CRAN-P (5/8/2025, 7:00:00 PM)

0.08

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.69M
Revenue(TTM)N/A
Net Income(TTM)-50.20K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.68
P/tB 4.68
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.64%
ROE -13.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.37%
ROA(5y)N/A
ROE(3y)-17.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 57.52
Quick Ratio 57.52
Altman-Z 158.56
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.81%
OCF growth 3YN/A
OCF growth 5YN/A

CRANSTOWN CAPITAL CORP / CRAN-P.CA FAQ

Can you provide the ChartMill fundamental rating for CRANSTOWN CAPITAL CORP?

ChartMill assigns a fundamental rating of 2 / 10 to CRAN-P.CA.


What is the valuation status for CRAN-P stock?

ChartMill assigns a valuation rating of 0 / 10 to CRANSTOWN CAPITAL CORP (CRAN-P.CA). This can be considered as Overvalued.


Can you provide the profitability details for CRANSTOWN CAPITAL CORP?

CRANSTOWN CAPITAL CORP (CRAN-P.CA) has a profitability rating of 0 / 10.